Bioassays are complex and challenging experiments to run reliably with accurate and dependable results. Consistent performance requires a controlled environment and qualified reagents; skilled analysts who understand cell physiology, regulatory requirements, and the latest techniques; and assay protocols that are intelligently developed, characterized, and validated. Here, BPI’s senior technical editor discusses bioassay best practices with representatives of the Biopharmaceutical Emerging Best Practices Association (BEBPA) organization. Topics span quality by design, assay validation, cell banking, potency testing and host-cell protein monitoring,…
Wednesday, October 30, 2019 Daily Archives
Cesca and HealthBanks jump on the CAR-TXpress in cell banking JV
Cesca Therapeutics and HealthBanks Biotech say their cell processing tech and banking JV will target CDMOs and immunology researchers. Under the agreement Cesca’s subsidiary ThermoGenesis will grant the newly formed joint venture – to be called ImmuneCyte Life Sciences – an exclusive license to its CAR-TXpress technology. The system is used to isolate blood components in a cGMP compliant manner. According to Cesca it is 16 times more efficient than ficoll gradient centrifugation-based cell processing methods. In addition to offering…